ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

EU To Fund Drug Research Proposals

by Marc S. Reisch
September 21, 2009 | APPEARED IN VOLUME 87, ISSUE 38

A partnership between the European Commission and the European Federation of Pharmaceutical Industries & Associations will issue a call at the end of October for research proposals in the fields of oncology, inflammatory diseases, and infectious diseases. The public-private partnership, known as the Innovative Medicines Initiative (IMI), plans to award $230 million to projects that investigate, for instance, imaging biomarkers for cancer drug development, aberrant adaptive immunity mechanisms, and ways to bridge the gap between animal models and humans. The EU Commissioner for Science & Research, Janez Potočnik, says he hopes the funding will help improve Europe’s attractiveness for pharmaceutical R&D. IMI awarded $337 million to 15 projects at the end of May (C&EN, May 25, page 16).

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment